VAX ON 2025 - Vivenko

Presidency

Paolo A. Ascierto, Director of Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute IRCCS “Fondazione G. Pascale”, Naples, Italy

Bernard A. Fox, Chief of Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Institute, Portland, Oregon, US

Rational

After decades of research and clinical trials, vaccines are beginning to impact patient outcomes. While the future is bright, we still have a long way to go.
This event will be an international meeting for experts to share and discuss the latest findings and future perspectives on cancer vaccines.
The objectives of the conference are to:

Present up-to-date data
Interpret clinical and scientific findings and predict potential impact
Recognize and characterize the hurdles that remain
Provide a vision for the future if hurdles are addressed

Abstract

The best abstracts will be selected by the Scientific Board as poster and oral communication.

Topics include:

Neoantigens
mRNA Vaccines
Dark Matter
Peptide Vaccines
Vaccines with anti‑PD‑1
Combination IO with Vaccines

Please download the Authors’ Guidelines
Submit your abstract to eventi@vivenko.net
Deadline abstract submission: 30 July 2025

Registration

Registration is free of charge for medical and clinical professionals
The official language is English.

For any information, please send an email to eventi@vivenko.net

Organizing Secretariat

Information

Clicca qui per registrarti all’evento